Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient is 18 years of age or older
Patient has had a history of migraine with or without aura
Patient is able to complete study questionnaire(s) and paper diary
You may not be if
Patient is pregnant or breast-feeding, or is a female expecting to conceive within the projected duration of the study
Patient has basilar or hemiplegic migraine headache, hepatitis or psychiatric conditions
Patient was older than 50 years of age at migraine onset
History of gastric or small intestinal surgery or has a disease that causes malabsorption
Patient has heart attack, unstable angina, coronary artery bypass surgery or other revascularization procedure, stroke, or transient ischemic attack 3 months before starting the study
Currently participating or has participated in a study with an investigational compound or device within 30 days of starting the study
Currently participating in a study with MK-0974 or MK-3207
Clareo Health | MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)
